{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T18:43:38Z","timestamp":1789670618844,"version":"4.0.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T00:00:00Z","timestamp":1745107200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T00:00:00Z","timestamp":1745107200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009827","name":"Alexandria University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009827","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Tuberculosis (TB) is a significant global public health concern. The incidence of extrapulmonary tuberculosis (EPTB) is increasing; however, comprehensive data on its epidemiological and clinical characteristics remain limited, especially among populations who are co-infected with human immunodeficiency virus (HIV) or hepatitis C virus (HCV). This study aimed to assess the incidence and predictors of EPTB in patients co-infected with HIV or HCV in Egypt. We conducted a retrospective cohort study on patients infected with TB who are treated in Egyptian chest hospitals from January 1 to December 31, 2023. Patients were categorized into pulmonary TB (PTB) and EPTB. Clinical data, including HIV or HCV co-infection status, were analyzed to identify risk factors and comorbidities associated with EPTB. Multilevel logistic regression was employed to examine predictors of EPTB. Among 7,245\u00a0TB patients, 42.5% were diagnosed with EPTB. Determinant of EPTB were HIV-positive (OR\u2009=\u20090.46, 95% CI: 0.30\u20130.71, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), being male (OR\u2009=\u20090.31, 95% CI: 0.27\u20130.35, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001 ), age (particularly children under 5 years) (OR\u2009=\u20094.75, 95% CI: 2.29\u20139.84, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001 ), urban residency (OR\u2009=\u20091.05, 95% CI: 0.87\u20131.27, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05), and comorbidities (OR\u2009=\u20090.59, 95% CI: 0.35\u20130.98, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). The most common sites for EPTB were the lymph nodes (27.10%) and pleural cavity\/effusion (24.60%). EPTB represents a substantial proportion of TB cases in Egypt, particularly among younger individuals and females. Despite the low percentage of HIV or HCV co-infection in EPTB cases, further analysis and diagnostic testing of undiagnosed patients are required. These findings underscore the need for targeted interventions and comprehensive care models for TB patients, especially in the context of HIV co-infection.<\/jats:p>","DOI":"10.1038\/s41598-025-95699-z","type":"journal-article","created":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T09:49:11Z","timestamp":1745142551000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Incidence and determinants of extrapulmonary tuberculosis in Egypt: a retrospective cohort study"],"prefix":"10.1038","volume":"15","author":[{"given":"Wagdy","family":"Amin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasha","family":"Ashmawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah Assem","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousra A.","family":"El-Maradny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neamat Hamdy","family":"Elsawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaimaa Abdallah","family":"Gebili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahla","family":"Gamaleldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7611-706X","authenticated-orcid":false,"given":"Ramy Mohamed","family":"Ghazy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,20]]},"reference":[{"key":"95699_CR1","doi-asserted-by":"crossref","unstructured":"Bagcchi, S. WHO\u2019s global tuberculosis report 2022. Lancet Microbe 4, e20 (2023).","DOI":"10.1016\/S2666-5247(22)00359-7"},{"key":"95699_CR2","unstructured":"World Health Organization (WHO). Global tuberculosis report. (2024)."},{"key":"95699_CR3","unstructured":"World Health Organization (WHO). Global tuberculosis report 2021. (2021). https:\/\/www.who.int\/publications\/i\/item\/9789240037021. Accessed 17 Jun 2024."},{"key":"95699_CR4","doi-asserted-by":"crossref","unstructured":"El-Mokhtar, M. A. et al. Hepatitis C virus affects tuberculosis-specific T cells in HIV-negative patients. Viruses 12, 101 (2020).","DOI":"10.3390\/v12010101"},{"key":"95699_CR5","unstructured":"World Health Organization (WHO). New report flags major increase in sexually transmitted infections, amidst challenges in HIV and hepatitis. (2024). https:\/\/www.who.int\/news\/item\/21-05-2024-new-report-flags-major-increase-in-sexually-transmitted-infections---amidst-challenges-in-hiv-and-hepatitis. Accessed 16 Jun 2024."},{"key":"95699_CR6","volume-title":"Global Hepatitis Report 2024 Action for Access in Low- and Middle-Income Countries","author":"World Health Organization (WHO)","year":"2024","unstructured":"World Health Organization (WHO). Global Hepatitis Report 2024 Action for Access in Low- and Middle-Income Countries (World Health Organization, 2024)."},{"key":"95699_CR7","unstructured":"World Health Organization (WHO). Egypt becomes the first country to achieve WHO validation on the path to elimination of hepatitis C. (2023). https:\/\/www.emro.who.int\/media\/news\/egypt-becomes-the-first-country-to-achieve-who-validation-on-the-path-to-elimination-of-hepatitis-c.html. Accessed 16 Jun 2024."},{"key":"95699_CR8","doi-asserted-by":"crossref","unstructured":"Lomtadze, N. et al. Hepatitis C virus co-infection increases the risk of anti-tuberculosis drug-induced hepatotoxicity among patients with pulmonary tuberculosis. PLoS One 8\u00a0(2013).","DOI":"10.1371\/journal.pone.0083892"},{"key":"95699_CR9","doi-asserted-by":"crossref","unstructured":"Altice, F. L. et al. The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and central Asia. Lancet 388, 1228-1248 (2016).","DOI":"10.1016\/S0140-6736(16)30856-X"},{"key":"95699_CR10","doi-asserted-by":"crossref","unstructured":"Behzadifar, M., Heydarvand, S., Behzadifar, M. & Bragazzi, N. L. Prevalence of hepatitis C virus in tuberculosis patients: A systematic review and Meta-Analysis. Ethiop. J. Health Sci. 29\u00a0(2019).","DOI":"10.4314\/ejhs.v29i1.17"},{"key":"95699_CR11","doi-asserted-by":"crossref","unstructured":"Kempker, R. R., Alghamdi, W. A., Al-Shaer, M. H., Burch, G. & Peloquin, C. A. A Pharmacology perspective on simultaneous tuberculosis and hepatitis C treatment. Antimicrob. Agents Chemother. 63, 10-1128 (2019).","DOI":"10.1128\/AAC.01215-19"},{"key":"95699_CR12","unstructured":"World Health Organization (WHO). HIV data and statistics. (2023). https:\/\/www.who.int\/teams\/global-hiv-hepatitis-and-stis-programmes\/hiv\/strategic-information\/hiv-data-and-statistics. Accessed 16 Jun 2024."},{"key":"95699_CR13","doi-asserted-by":"crossref","unstructured":"Heidary, M. et al. Tuberculosis challenges: resistance, co-infection, diagnosis, and treatment. Eur. J. Microbiol. Immunol. 12, 1-17 (2022).","DOI":"10.1556\/1886.2021.00021"},{"key":"95699_CR14","unstructured":"Global Tuberculosis Report. World Health Organization; 2023. (2023)."},{"key":"95699_CR15","doi-asserted-by":"crossref","unstructured":"Rolo, M., Gonz\u00e1lez-Blanco, B., Reyes, C. A., Rosillo, N. & L\u00f3pez-Roa, P. Epidemiology and factors associated with Extra-pulmonary tuberculosis in a Low-prevalence area. J. Clin. Tuberc Other Mycobact. Dis. 32, 100377 (2023).","DOI":"10.1016\/j.jctube.2023.100377"},{"key":"95699_CR16","doi-asserted-by":"crossref","unstructured":"Jawed, A. et al. Better Understanding extrapulmonary tuberculosis: A scoping review of public health impact in Pakistan, Afghanistan, India, and Bangladesh. Health Sci. Rep. 6, 1357 (2023).","DOI":"10.1002\/hsr2.1357"},{"key":"95699_CR17","doi-asserted-by":"crossref","unstructured":"Hailu, S. et al. Prevalence of extra-pulmonary tuberculosis in Africa: A systematic review and meta-analysis. Trop. Med. Int. Health. 29, 257-265 (2024).","DOI":"10.1111\/tmi.13970"},{"key":"95699_CR18","volume-title":"National Tuberculosis Control Guidelines","author":"Egyptian Ministry of Health and Population","year":"2022","unstructured":"Egyptian Ministry of Health and Population. National Tuberculosis Control Guidelines (Egyptian Ministry of Health and population, 2022)."},{"key":"95699_CR19","unstructured":"Egyptian Ministry of Health and Population. National HIV\/AIDS Clinical Care: A Reference Guide for Physicians. (2017)."},{"key":"95699_CR20","volume-title":"Plan of Action for the Prevention","author":"Egyptian Ministry of Health and Population","year":"2014","unstructured":"Egyptian Ministry of Health and Population. Plan of Action for the Prevention (Care &amp; Treatment of Viral Hepatitis, 2014)."},{"key":"95699_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v067.i01","volume":"67","author":"D Bates","year":"2015","unstructured":"Bates, D., M\u00e4chler, M., Bolker, B. M. & Walker, S. C. Fitting linear Mixed-Effects models using lme4. J. Stat. Softw. 67, 1\u201348 (2015).","journal-title":"J. Stat. Softw."},{"key":"95699_CR22","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.jml.2012.11.001","volume":"68","author":"DJ Barr","year":"2013","unstructured":"Barr, D. J., Levy, R., Scheepers, C. & Tily, H. J. Random effects structure for confirmatory hypothesis testing: keep it maximal. J. Mem. Lang. 68, 255\u2013278 (2013).","journal-title":"J. Mem. Lang."},{"key":"95699_CR23","unstructured":"Nations, U. Human Development Report 2023-24. Human Development Reports. (2024)."},{"key":"95699_CR24","doi-asserted-by":"crossref","unstructured":"Sama, J. N. et al. High proportion of extrapulmonary tuberculosis in a low prevalence setting: a retrospective cohort study. Public. Health. 138, 101-107 (2016).","DOI":"10.1016\/j.puhe.2016.03.033"},{"key":"95699_CR25","doi-asserted-by":"crossref","unstructured":"Al-Otaibi, F. & El Hazmi, M. Extra-pulmonary tuberculosis in Saudi Arabia. Indian J. Pathol. Microbiol. 53, 227-231 (2010).","DOI":"10.4103\/0377-4929.64327"},{"key":"95699_CR26","doi-asserted-by":"crossref","unstructured":"Peto, H. M., Pratt, R. H., Harrington, T. A., LoBue, P. A. & Armstrong, L. R. Epidemiology of extrapulmonary tuberculosis in the united States, 1993\u20132006. Clin. Infect. Dis. 49, 1350-1357 (2009).","DOI":"10.1086\/605559"},{"key":"95699_CR27","doi-asserted-by":"crossref","unstructured":"Sandgren, A., Hollo, V. & van der Werf, M. J. Extrapulmonary tuberculosis in the European union and European economic area, 2002 to 2011. Eurosurveillance 18\u00a0(2013).","DOI":"10.2807\/ese.18.12.20431-en"},{"key":"95699_CR28","unstructured":"Ayed, H. et al. Extrapulmonary tuberculosis: update on the epidemiology, risk factors and prevention strategies. Int. J. Trop. Dis. 1\u00a0(2018)."},{"key":"95699_CR29","doi-asserted-by":"crossref","unstructured":"Donald, P. R., Marais, B. J. & Barry, C. E. Age and the epidemiology and pathogenesis of tuberculosis. Lancet 375, 1852-1854 (2010).","DOI":"10.1016\/S0140-6736(10)60580-6"},{"key":"95699_CR30","doi-asserted-by":"publisher","first-page":"32","DOI":"10.26719\/emhj.24.003","volume":"30","author":"MO Nour","year":"2024","unstructured":"Nour, M. O. & Nour, S. O. Systematic review and meta-analysis of the prevalence, incidence and treatment outcomes of tuberculosis in Egypt: updated overview. East. Mediterr. Health J. 30, 32\u201345 (2024).","journal-title":"East. Mediterr. Health J."},{"key":"95699_CR31","doi-asserted-by":"crossref","unstructured":"Fahim, N., Mahmood, Y. & Ezz elarab, H. Retrospective study of the pattern of pulmonary and extrapulmonary tuberculosis cases in Ain Shams university hospitals during the period of 2016\u2013 2022. Afro-Egyptian J. Infect. Endemic Dis. 13, 270-279 (2023).","DOI":"10.21608\/aeji.2023.236728.1321"},{"key":"95699_CR32","doi-asserted-by":"crossref","unstructured":"El Malik, A. R. A., El Wahab, A. E. E. A. & Eltrawy, H. H. Retrospective study of pulmonary and extrapulmonary tuberculosis cases in Giza Governorate during the period of 2014\u20132018. Egypt. J. Bronchol. 15, 24 (2021).","DOI":"10.1186\/s43168-021-00072-z"},{"key":"95699_CR33","doi-asserted-by":"crossref","unstructured":"Tahseen, S. et al. Extrapulmonary tuberculosis in Pakistan- A nation-wide multicenter retrospective study. PLoS One 15\u00a0(2020).","DOI":"10.1371\/journal.pone.0232134"},{"key":"95699_CR34","unstructured":"Kaba, \u00d6. et al. Evaluation of cases of pediatric extrapulmonary tuberculosis: A single center experience. Turk. Pediatri Ars 54, 86 (2019)."},{"key":"95699_CR35","doi-asserted-by":"crossref","unstructured":"Pang, Y. et al. Epidemiology of extrapulmonary tuberculosis among inpatients, China, 2008\u20132017. Emerg. Infect. Dis. 25, 457 (2019).","DOI":"10.3201\/eid2503.180572"},{"key":"95699_CR36","doi-asserted-by":"crossref","unstructured":"Alwani, A. K., Al-Aarag, A. H., Omar, M. M. & Hibah, N. A. A. Incidence of tuberculosis before and after DOTS (direct observed therapy short course strategy) implementation in El-Behira Governorate, Egypt. Egypt. J. Bronchol. 9, 101-108 (2015).","DOI":"10.4103\/1687-8426.153665"},{"key":"95699_CR37","doi-asserted-by":"crossref","unstructured":"Mohammadien, H., Alkhayat, K., Hamed, A. & Shaaban, M. Patterns, trends and treatment outcomes of extra-pulmonary tuberculosis in Sohag, upper Egypt. Egypt. J. Chest Dis. Tuberculosis 66, 313-316 (2017).","DOI":"10.1016\/j.ejcdt.2017.02.001"},{"key":"95699_CR38","doi-asserted-by":"crossref","unstructured":"Boutros, S. & Skordis, J. HIV\/AIDS surveillance in Egypt: current status and future challenges. East. Mediterr. Health J. 16\u00a0(2010).","DOI":"10.26719\/2010.16.3.251"},{"key":"95699_CR39","doi-asserted-by":"crossref","unstructured":"Jacob, S. et al. Prevalence of diabetes mellitus and HIV\/AIDS among tuberculosis patients in Kerala. J. Family Med. Prim. Care 9\u00a0(2020).","DOI":"10.4103\/jfmpc.jfmpc_1583_20"},{"key":"95699_CR40","volume-title":"Prevalence of extrapulmonary tuberculosis among people living with HIV\/AIDS in sub-saharan Africa: A systemic review and meta-analysis","author":"H Mohammed","year":"2018","unstructured":"Mohammed, H., Assefa, N. & Mengistie, B. Prevalence of extrapulmonary tuberculosis among people living with HIV\/AIDS in sub-saharan Africa: A systemic review and meta-analysis Vol. 10 (HIV\/AIDS - Research and Palliative Care, 2018)."},{"key":"95699_CR41","doi-asserted-by":"crossref","unstructured":"Kyagulanyi, E. et al. The prevalence of concurrent pulmonary and extrapulmonary tuberculosis in Uganda: a retrospective study. Ther. Adv. Infect. Dis. 9\u00a0(2022).","DOI":"10.1177\/20499361221107304"},{"key":"95699_CR42","doi-asserted-by":"crossref","unstructured":"Mohan, A. et al. Provider-initiated HIV testing & counselling in incident tuberculosis cases under National TB programme conditions at a tertiary care teaching hospital in Tirupati, South India. Indian J. Med. Res. 146, 774-779 (2017).","DOI":"10.4103\/ijmr.IJMR_639_15"},{"key":"95699_CR43","doi-asserted-by":"crossref","unstructured":"Shastri, S., Naik, B., Shet, A., Rewari, B. & De Costa, A. TB treatment outcomes among TB-HIV co-infections in Karnataka, India: how do these compare with non-HIV tuberculosis outcomes in the Province?? BMC Public. Health 13, 1-6 (2013).","DOI":"10.1186\/1471-2458-13-838"},{"key":"95699_CR44","unstructured":"Tabarsi, P. et al. Clinical and laboratory profile of patients with Tuberculosis\/HIV coinfection at a National referral centre: A case series. East. Mediterr. Health J. 14\u00a0(2008)."},{"key":"95699_CR45","doi-asserted-by":"crossref","unstructured":"Kamath, R., Sharma, V., Pattanshetty, S., Hegde, M. B. & Chandrasekaran, V. HIV-TB coinfection: Clinico-epidemiological determinants at an antiretroviral therapy center in Southern India. Lung India 30, 302-306 (2013).","DOI":"10.4103\/0970-2113.120605"},{"key":"95699_CR46","first-page":"204","volume":"23","author":"CS Philipose","year":"2024","unstructured":"Philipose, C. S., Sinchana, K. M., Haridas, H., Ramapuram, J. & Rai, S. Clinico-pathological profile of patients with HIV and tuberculosis co-infection. HIV AIDS Rev. 23, 204\u2013208 (2024).","journal-title":"HIV AIDS Rev."},{"key":"95699_CR47","unstructured":"Antwal, M. et al. Clinical profile of HIV infected patients attending a HIV referral clinic in Pune, India. Indian Med. Res. 140, 271-277 (2014)."},{"key":"95699_CR48","doi-asserted-by":"crossref","unstructured":"Magee, M. J., Foote, M., Ray, S. M., Gandhi, N. R. & Kempker, R. R. Diabetes mellitus and extrapulmonary tuberculosis: site distribution and risk of mortality. Epidemiol. Infect. 144, 2209-2216 (2016).","DOI":"10.1017\/S0950268816000364"},{"key":"95699_CR49","doi-asserted-by":"crossref","unstructured":"Fallahzadeh, H., Khazaei, Z., Najafi, M. L., Pordanjani, S. R. & Goodarzi, E. Distribution incidence, mortality of tuberculosis and human development index in Iran: estimates from the global burden of disease study 2019. BMC Public. Health 23, 2404 (2023).","DOI":"10.1186\/s12889-023-17114-4"},{"key":"95699_CR50","doi-asserted-by":"crossref","unstructured":"Taylan, M. et al. Effect of human development index parameters on tuberculosis incidence in Turkish provinces. J. Infect. Dev. Ctries. 10, 1183\u20131190 (2016).","DOI":"10.3855\/jidc.8101"},{"key":"95699_CR51","doi-asserted-by":"crossref","unstructured":"Harling, G. & Castro, M. C. A Spatial analysis of social and economic determinants of tuberculosis in Brazil. Health Place 25, 56\u201367 (2014).","DOI":"10.1016\/j.healthplace.2013.10.008"},{"key":"95699_CR52","doi-asserted-by":"crossref","unstructured":"Ghazy, R. M. et al. Catastrophic costs among Tuberculosis-Affected households in Egypt: magnitude, cost drivers, and coping strategies. Int. J. Environ. Res. Public. Health 20, 2640 (2023).","DOI":"10.3390\/ijerph20032640"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-95699-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-95699-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-95699-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T09:49:26Z","timestamp":1745142566000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-95699-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,20]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["95699"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-95699-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,20]]},"assertion":[{"value":"22 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study protocol was reviewed and approved by the Research Ethics Committee of the Egyptian Ministry of Health (MoHP-REC) under Communication\/Decision Number 16-2023\/17. Informed consent was obtained from all study participants or their legal guardians, permitting the use of their medical information for research purposes. This consent was documented in their medical records as part of the standard procedure before treatment initiation. This study adhered to the ethical principles outlined in the Declaration of Helsinki and relevant national guidelines to ensure the protection and rights of all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not available.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"13631"}}